Deposition of cannabinoids in hair after long-term use of cannabis

Forensic Science International

Volumn 170, Issue 1, 2007, Pages 46-50

  Skopp, Gisela ^a   Strohbeck Kuehner, Peter ^a   Mann, Karl ^b   Hermann, Derik ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Cannabinoids; Correlation; Hair analysis; Self report

Indexed keywords

CANNABIDIOL; CANNABINOID DERIVATIVE; CANNABINOL; CANNABIS; DRONABINOL;

ADULT; ARTICLE; CANNABIS ADDICTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; GAS CHROMATOGRAPHY; HAIR ANALYSIS; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; MEDICAL INFORMATION; PRIORITY JOURNAL; SCALP HAIR;

EID: 34250901929     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2006.09.003     Document Type: Article

References (52)

1. Koren G., Chan D., Klein J., and Karaskov T. Estimation of fetal exposure to drugs of abuse, environmental tobacco smoke, and ethanol. Ther. Drug. Monit. 24 (2002) 23-25
2. Nakahara Y. Hair analysis for abused and therapeutic drugs. J. Chromatogr. B Biomed. Sci. Appl. 733 (1999) 161-180
3. Gaillard Y., and Pepin G. Testing hair for pharmaceuticals. J. Chromatogr. B Biomed. Sci. Appl. 733 (1999) 231-246
4. Pragst F., Rothe M., Spiegel K., and Sporkert F. Illegal and therapeutic drug concentrations in hair segments-a time table of drug exposure?. Forensic Sci. Rev. 10 (1998) 81-111
5. Miller M.L., Donelly B., and Martz R.M. The forensic application of testing hair for drugs of abuse. NIDA Res. Monogr. 167 (1997) 146-160
6. Sato H., Uematsu T., Yamada K., and Nakashima M. Chlorpromazine in scalp hair as an index of dosage history: comparison with simultaneously measured haloperidol. Eur. J. Clin. Pharmacol. 44 (1993) 439-444
7. Baumgartner W.A., Hill V.A., and Blahd W.H. Hair analysis for drugs of abuse. J. Forensic Sci. 34 (1989) 1433-1453
8. Pötsch L., and Skopp G. Inkorporation von Fremdsubstanzen in Haare. In: Madea B., and Mußhoff F. (Eds). Haaranalytik-Technik und Interpretation in Medizin und Recht (2004), Deutscher Ärzte-Verlag, Köln, Germany 29-98
9. Kintz P., Marescaux C., and Mangin P. Testing human hair for carbamazepine: is hair investigation suitable for drug monitoring?. Hum. Exp. Toxicol. 14 (1995) 812-815
10. Mizuno A., Uematsu T., and Nakashima M. Simultaneous determination of ofloxacin, norofloxacin, and ciprofloxacin in human hair by high-performance liquid chromatography and fluorescence detection. J. Chromatogr. B Biomed. Appl. 653 (1994) 187-193
11. Goulle J.P., Noyon J., Layet A., Rapoport N.F., Vaschalde Y., Pignier Y., Bouige D., and Jouen F. Phenobarbital in hair and drug monitoring. Forensic Sci. Int. 70 (1995) 191-202
12. Rollins D.E., Wilkins D.G., and Krueger G.G. Codeine disposition in human hair after single and multiple doses. Eur. J. Clin. Pharmacol. 50 5 (1996) 391-397
13. Rollins D.E., Wilkins D.G., Krueger G.G., Augsburger M.P., Mizuno A., O'Neal C., Borges C.R., and Slawson M.H. The effect of hair color on the incorporation of codeine into human hair. J. Anal. Toxicol. 27 (2003) 545-551
14. Gygi S.P., Colon F., Raftogianis R.B., Galinsky R.E., Wilkins D.G., and Rollins D.E. Dose-related distribution of codeine and its metabolite into rat hair. Drug Metab. Dipos. 24 (1996) 282-287
15. Henderson G.L., Harkey M.R., and Zhou C. Incorporation of isotopically labeled cocaine and metabolites into human hair: 1. Dose-response-relationships. J. Anal. Toxicol. 20 (1996) 1-12
16. Scheidweiler K.B., Cone E.J., Moolchan E.T., and Huestis M.A. Dose-related distribution of codeine, cocaine, and metabolites into human hair following controlled oral codeine and subcutenous cocaine administration. J. Pharmacol. Exp. Ther. 313 (2005) 909-915
17. Pragst F., Rothe M., Hunger J., and Thor S. Structural and concentration effects on the disposition of tricyclic antidepressants in human hair. Forensic Sci. Int. 84 (1997) 225-236
18. Uematsu T., Matsuno H., Hirayama H., Hasegawa K., and Nakashima M. Steady-state pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients: analysis of factors determining their concentrations in hair. J. Pharm. Sci. 81 (1992) 1008-1011
19. Poetsch L., Eser H.P., Skopp G., and Moeller M.R. On drug analysis in hair. VII. Investigations on patients during methadone treatment under constant dose. Rechtsmedizin 8 (1998) 47-50
20. Girod C., and Staub C. Methadone and EDDP in hair from human subjects following a maintenance program: results of a pilot study. Forensic Sci. Int. 117 (2001) 175-184
21. Paterson S., Cordero R., McPhillips M., and Carman S. Interindividual dose/concentration relationship for methadone in hair. J. Anal. Toxicol. 27 (2003) 20-23
22. Miezkowski T. The use of hair analysis for the detection of drugs: an overview. J. Clin. Forensic Med. 3 (1996) 59-71
23. 9-THC-COOH. Forensic Sci. Int. 128 (2002) 66-78
24. Miezkowski T. Assessing the potential of a "color effect" for hair analysis of 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol: analysis of a large sample of hair specimens. Life Sci. 74 (2003) 463-469
25. Thorspecken J., Skopp G., and Pötsch L. In vitro contamination of hair by marijuana smoke. Clin. Chem. 50 (2004) 596-602
26. Gygi S.P., Joseph R.E., Cone E.J., Wilkins D.G., and Rollins D.E. Incorporation of codeine and metabolites into hair. Drug Metab. Dispos. 24 (1996) 495-501
27. Clauwaert K.M., Van Bocxlaer J.F., Lambert W.E., and De Leenheer A.P. Segmental analysis for cocaine and metabolites by HPLC in hair of suspected drug overdose cases. Forensic Sci. Int. 110 (2000) 157-166
28. Sachs H., and Kintz P. Testing for drugs in hair. Critical review of chromatographic procedures since 1992. J. Chromatogr. B 713 (1998) 147-161
29. Kauert G., and Röhrich J. Concentrations of delta 9-tetrahydrocannabinol, cocaine and 6-acetylmorphine in hair of drug abusers. Int. J. Legal Med. 108 (1996) 294-299
30. Skopp G., Pötsch L., and Mauden M. Stability of cannabinoids in hair exposed to sunlight. Clin. Chem. 46 (2000) 1846-1848
31. Deutsches Institut für Normung, DIN32645 Chemische Analytik-Nachweis-, Erfassungs- und Bestimmungsgrenze, Beuth Verlag, Berlin, Germany, 1994, pp. 3-10.
32. Pichini S., Poudevida S., Pujadas M., Menoyo E., Pacifici R., Farre M., and de la Torre R. Assessment of chronic exposure to MDMA in a group of consumers by segmental hair analysis. Ther. Drug Monit. 28 (2006) 106-109
33. Pepin G., and Gaillard Y. Concordance between self-reported drug use and findings in hair about cocaine and heroin. Forensic Sci. Int. 84 (1997) 37-41
34. Green S.J., and Wilson J.F. Evidence for saturable incorporation of methadone into rat hair: relationship among oral dose, plasma concentration, and hair content. Ther. Drug Monit. 18 (1996) 710-713
35. Clarke R.C., and Watson D.P. Die Botanik natürlicher Cannabismedikamente. In: Grotenhermen F. (Ed). Cannabis und Cannabinoide (2001), Hans Huber Verlag, Bern, Switzerland 21-32
36. 9-tetrahydrocannabinol, cannabinol, and cannabidiol. J. Anal. Toxicol. 20 (1996) 13-16
37. Tjerdeema R.S. The pyrolysis of cannabinoids. Rev. Environ. Contam. Toxicol. 99 (1987) 61-81
38. 9-tetrahydrocannabinol and cannabidiol. Science 172 (1971) 1158-1159
39. Chiarotti M., and Costamagna L. Analysis of 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in biological samples by gas chromatography/mass spectrometry. Forensic Sci. Int. 114 (2000) 1-6
40. Sachs H., and Dressler U. Detection of THCCOOH in hair by MSD-NCI after HPLC clean-up. Forensic Sci. Int. 107 (2000) 239-247
41. Skopp G., Pötsch L., and Moeller M.R. On cosmetically treated hair-aspects and pitfalls of interpretation. Forensic Sci. Int. 84 (1997) 42-43
42. Harkey M.R. Anatomy and physiology of hair. Forensic Sci. Int. 63 (1993) 9-18
43. 8-tetrahydrocannabinol, cannabidiol and cannabinol. J. Pharm. Pharmacol. 56 (2004) 291-297
44. Challapalli P.V.N., and Stinchkomb A.L. In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation. Int. J. Pharm. 241 (2002) 329-339
45. Samyn N., De Boeck G., and Verstraete A.G. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers. J. Forensic Sci. 47 (2002) 1380-1387
46. Saito T., Wtsadik A., Scheidweiler K.B., Fortner N., Takeichi S., and Huestis M.A. Validated gas chromatographic-negative ion chemical ionization mass spectrometric method for delta(9)-tetrahydrocannabinol in sweat patches. Clin. Chem. 50 11 (2004) 2083-2090
47. Kronstrand R., Förstberg-Petersen S., Kagedal B., Ahlner J., and Larson G. Codeine concentration in hair after oral administration is dependent on melanin content. Clin. Chem. 45 (1999) 1485-1494
48. Gygi S.P., Wilkins D.A., and Rollins D.E. A comparison of phenobarbital and codeine incorporation into pigmented and nonpigmented rat hair. J. Pharm. Sci. 86 (1997) 209-214
49. 9-tetrahydrocannabinol, into hair. J. Anal. Toxicol. 30 (2006) 139-140
50. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokinet. 42 (2003) 327-360
51. Jaeger W., Benet L.Z., and Bornheim L.M. Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human liver microsomes. Xenobiotika 26 (1996) 275-284
52. Bornheim L.M., and Grillo M.P. Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involement of cannabidiol-hydroxyquinone as an P450 inactivator. Chem. Res. Toxicol. 11 (1998) 1209-1216